Your metabolic history can influence how your body responds
By improving insulin sensitivity and reducing inflammatory markers, Semaglutide addresses the root causes of metabolic syndrome, fostering metabolic health
For instance, on January 2, 2026, Eli Lilly announced that its self-developed GIP/GLP-1 receptor dual agonist tirzepatide injection, Mounjaro, was officially launched in China
Read the Instructions for Use for the pen carefully before using Mounjaro KwikPen
While most patients return to their baseline state, individual responses vary, and some may experience more pronounced hunger or cravings during the adjustment period
Diabetologia 65 , 12511261 (2022)